Marked decrease of tacrolimus blood concentration caused by compound Chinese herbal granules in a patient with...

Area of Science:

• Pharmacology
• Nephrology
• Traditional Chinese Medicine

Background:

• Tacrolimus blood concentration is crucial for efficacy and safety in organ transplant and autoimmune disease patients.
• Co-administration with other drugs can significantly alter tacrolimus levels.
• The potential for herb-drug interactions is a growing concern, especially in regions like China where traditional herbal medicines are prevalent.

Observation:

• A case study involving a young girl with refractory nephrotic syndrome is presented.
• The patient experienced a near 50% reduction in tacrolimus blood concentration without any dosage adjustment.
• Concurrent treatments included nebulizer therapy, cyclophosphamide, and a compound Chinese herbal medicine.

Findings:

• The introduction of a compound Chinese herbal medicine was identified as the most probable cause for the decreased tacrolimus levels.
• Specifically, Radix Astragali, a component of the herbal granules, is suspected to be responsible for this interaction.
• This observation underscores the need for vigilance regarding herb-drug interactions in clinical practice.

Implications:

• Clinicians should be aware of potential interactions between Chinese herbal medicines and immunosuppressants like tacrolimus.
• Monitoring tacrolimus levels is essential when initiating or altering herbal medicine use in patients.
• Further research is warranted to elucidate the mechanisms of such herb-drug interactions and establish clinical guidelines.